Furthermore, the effect on lymphoma cell mobility may partially contribute to lymphoma dissemination and aggressiveness, typically observed in DLBCL patients that express high levels of miR-155 and lack HGAL expression [100]. The gene discussed is GCSAM; the disease is lymphoma.